Number of shares and voting rights as at November 30th, 2011

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)

Press release

Avignon, December 7th, 2011

30.11.2011

Total number of outstanding shares forming the capital 5,034,432 ordinary shares under ISIN FR0000054694 1,283,840 shares resulting from the exercise of warrants under ISIN FR0000054694 1,387,308 preferred shares under ISIN FR0010833251	7,705,580
Total number of outstanding shares forming the capital with voting rights 5,034,432 ordinary shares under ISIN FR0000054694 1,283,840 shares resulting from the exercise of warrants under ISIN FR0000054694	6,318,272
Number of shares with double voting rights	212,190
Total number of gross voting rights	6,530,462
Number of shares without voting rights 0 registered share 4,555 bearer shares in the frame of the liquidity contract	- 4,555
Total number of exercisable voting rights*	6,525,907

*Real number of voting rights = total number of voting rights – number of shares without voting rights

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.fr

Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)

Number of shares comprising the capital: 7,705,580

6,318,272 ordinary shares (ISIN FR0000054694)

1,387,308 preferred shares (ISIN FR0010833251)

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP

About Naturex

NATUREX is the global leader in specialty plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

NATUREX's head office is based in Avignon. The company employs more than 1,000 people with high-performance manufacturing operations across 13 sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 18 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).

NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

• Contacts
Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 [email protected]	Thierry Lambert Vice-President and Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 [email protected]
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 [email protected]	Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 [email protected]

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-

Communiqué intégral et original au format PDF :

http://www.actusnews.com/documents_communiques/ACTUS-0-26066-2011.12.07-nb-of-shares-and-voting-rights-30-november-2011.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Quelle: Actusnews